FX.co ★ Forex-Nachrichten und Ereignisse. Review und Analyse der wirtschaftlichen Ereignisse

The University of Michigan's updated figures, released on Friday, indicated that consumer sentiment in the U.S. fell more than initially predicted in April. The University's consumer sentiment index for April...

The U.S. Consumer Product Safety Commission (CPSC) has announced multiple product recalls, due to various reasons, of items such as earmuffs, toy racing cars, log splitters and cylinder kits, cribs...

Tompkins Financial Corporation (TMP) reported a decline in profit for the first quarter of the year compared to the same period from the previous year. The company's earnings reached...

Johnson & Johnson's subsidiary, Janssen-Cilag International NV, revealed on Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has advocated for the approval of Rybrevant...

Bristol Myers Squibb, a leading pharmaceutical company, recently announced that their drug, Opdivo, is on its way to earning European approval. The Committee for Medicinal Products for Human Use (CHMP)...

Biopharmaceutical giant, Amgen, has announced its plans to submit a Marketing Authorization Application for Teprotumumab to the European Medicines Agency. Teprotumumab is a fully human monoclonal antibody and a targeted...

Swedish biopharmaceutical company, Swedish Orphan Biovitrum AB, has received a positive recommendation from the Committee for Medicinal Products for Human Use under the European Medicines Agency. This recommendation supports...

Gilead Sciences, Inc. recently announced that the U.S. Food and Drug Administration (FDA) has approved an updated label for Biktarvy. The new label now includes extra data that reinforces...

Shares of Newell Brands Inc. showed a more than 7 percent increase in the pre-market trading on Friday, pushing the price to $7.48. This rise was due to the company...

Takeda (TAK) recently disclosed that the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended that fruquintinib be approved. Fruquintinib, a selective inhibitor of vascular endothelial growth...